Kimia Biosciences informs about updates

29 Apr 2020 Evaluate

Kimia Biosciences has informed that the Company has been granted permission to Manufacturing and Marketing of New Active pharmaceutical Ingredient Azelnidipine drug by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi - 110002 (India) Vide permission No. MF/SND/20/000114 dated 28-April-2020 in FORM CT-22 under Drugs & Cosmetics Acts & Rules thereunder.

The above information is a part of company’s filings submitted to BSE.



Kimia Biosciences Share Price

43.00 -0.40 (-0.92%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.